Your browser doesn't support javascript.
loading
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration.
Guerrini, Giuditta; Gioria, Sabrina; Sauer, Aisha V; Lucchesi, Simone; Montagnani, Francesca; Pastore, Gabiria; Ciabattini, Annalisa; Medaglini, Donata; Calzolai, Luigi.
Afiliação
  • Guerrini G; European Commission, Joint Research Centre (JRC), Ispra, Italy.
  • Gioria S; European Commission, Joint Research Centre (JRC), Ispra, Italy.
  • Sauer AV; European Commission, Joint Research Centre (JRC), Ispra, Italy.
  • Lucchesi S; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Montagnani F; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Pastore G; Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena, 53100 Siena, Italy.
  • Ciabattini A; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Medaglini D; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
  • Calzolai L; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Int J Mol Sci ; 23(16)2022 Aug 09.
Article em En | MEDLINE | ID: mdl-36012103

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália